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Abstract
Background: We report two cases of anisakiasis lesions that were initially suspected to be recurrence of
gynecological cancer by positron emission tomography-computed tomography (PET-CT). Both cases were
extragastrointestinal anisakiasis that is very rare.
Case presentation: The first case was a patient with endometrial cancer. At 19 months after surgery, a new low
density area of 2 cm in diameter in liver segment 4 was found on follow-up CT. In PET-CT, the lesion had abnormal
18fluoro-deoxyglucose (FDG) uptake with elevation in the delayed phase, with no other site showing FDG uptake.
Partial liver resection was performed. A pathological examination revealed no evidence of malignancy, but showed
necrotic granuloma with severe eosinophil infiltration and an irregular material with a lumen structure in the center.
Parasitosis was suspected and consultation with the National Institute of Infectious Diseases (NIID) showed the
larvae to be Anisakis simplex sensu stricto by genetic examination.
The second case was a patient with low-grade endometrial stromal sarcoma (LG-ESS). At 8 months after surgery,
swelling of the mediastinal lymph nodes was detected on CT and peripheral T-cell lymphoma was diagnosed by
biopsy. A new peritoneal lesion with abnormal FDG uptake was detected on pre-treatment PET-CT and this lesion
was increased in size on post-treatment PET-CT. Tumorectomy was performed based on suspected dissemination of
LG-ESS recurrence. The findings in a pathological examination were similar to the first case and we again consulted
the NIID. The larvae was identified as Anisakis pegreffi, which is a rare pathogen in humans.
Having experienced these rare cases, we investigated the mechanisms of FDG uptake in parasitosis lesions by
immunohistochemical staining using antibodies to glucose transporter type 1 (GLUT-1) and hexokinase type 2 (HK-2).
While infiltrated eosinophils were negative, macrophages demonstrated positive for both antibodies. Therefore,
mechanisms behind FDG uptake may involve macrophages, which is common among various granulomas. This is the
first report to investigate parasitosis in such a way.
Conclusion: These cases suggest that anisakiasis is a potential differential diagnosis for a lesion with FDG uptake in
PET-CT, and that it is difficult to distinguish this disease from a recurrent tumor using PET-CT alone.
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Background
Positron emission tomography (PET)-computed tomog-
raphy (CT) is increasingly commonly used for various
cancers, especially for detection of a metastasis or recurrent
lesion. For gynecological cancers, PET-CT is used for
examination of possible malignancy of lesions detected by
CT or MRI in postoperative follow-up [1]. A lesion with
abnormal uptake indicates possible recurrence, and PET-
CT is believed to have better accuracy for determining
malignancy compared to CT or MRI [2–4]. Surgery is
rarely performed for postoperative recurrence, but an exact
diagnosis is difficult without a pathological examination.
Thus, a lesion that mimics tumor recurrence can lead to
unnecessary surgery, chemotherapy, and radiotherapy.
Anisakiasis is relatively common in East Asia due to con-
sumption of raw fish. Anisakiasis often presents with acute
abdominal symptoms caused by an allergic reaction in the
gastric mucosa. Anisakisis usually infect gastric or intestinal
walls, and the feature of the images including PET-CT have
been reported [5, 6]. Extragastrointestinal anisakiasis is less
common, but such cases have been reported [7–9]. After
penetrating the bowel wall, Anisakis produce a granuloma
as their bodies collapse with time. Incidental detection of
this lesion is difficult to distinguish from recurrence in pa-
tients with a history of malignancy. This may result in un-
necessary resection, and in some cases the collapsing worm
body may make the final diagnosis difficult, even after
resection.
We experienced two cases of extragastrointestinal anisa-
kiasis in which a recurrent gynecological tumor was initially
suspected on imaging. PET-CT showed that the lesions had
abnormal uptake in both cases. Even PET-CT could not
distinguish between anisakiasis and a tumor metastasis, and
diagnosis in the second case was further complicated by
collapse of the worm body. A polymerase chain reaction
(PCR) using a specific primer for an Anisakis-specific re-
gion confirmed anisakiasis in both cases.
Besides, we investigated the mechanism of FDG up-
take to granuloma of parasitosis. These cases are rare
but reported already, however, the mechanisms are still
unknown. We investigated it by immunostaining using
anti-bodies to glucose transporter type 1 (GLUT-1) and
hexokinase type 2 (HK-2), which are recognized as the
key factors of FDG uptake in PET.
We describe these two cases with a literature review
and molecular biological investigation. We suggest
that anisakiasis should be a differential diagnosis for a
solitary lesion detected on PET-CT, and we show the
utility of PCR for diagnosis of anisakiasis.
Case presentation
Case 1
The patient was a 44-year-old woman who had been
diagnosed with endometrial cancer. She underwent semi-
radical hysterectomy, bilateral salpingo-oophorectomy, pel-
vic and paraaortic lymph node dissection, and partial
omentectomy. A pathological examination revealed that
the tumor was grade 2 endometrioid adenocarcinoma with
more than 50 % myometrial invasion, and clinical stage Ic
(FIGO 1988). Given the intermediate risk of recurrence
based on the pathological result, she received adjuvant
chemotherapy of 6 cycles of a cyclophosphamide-
adriamycin-cisplatin (CAP) regimen.
Follow-up CT performed 19 months after surgery de-
tected a new low density area of 15 mm in diameter in
segment 4 of the liver (Fig. 1). Serum tumor markers in-
cluding CA125 and CA19-9 were not elevated, and were
similar to the levels before initial therapy. Data from blood
tests are shown in Table 1. MRI showed a liver tumor with
a high intensity signal in diffusion-weighted imaging
(DWI). In a dynamic study using gadolinium ethoxybenzyl
diethylenetriaminepentaacetic acid (Gd-EOB-DTPA),
early staining in the arterial phase was unclear and the le-
sion gave a low intensity signal in the hepatobiliary phase
(Fig. 2). These findings were compatible with a metastatic
tumor.
PET-CT was performed to confirm the presence of a ma-
lignant liver tumor and to search for other metastases. The
liver lesion had no specific 18fluoro-deoxyglucose (FDG)
uptake compared with normal liver tissue in the early
phase, and this was elevated in the delayed phase (standard-
ized uptake value (SUV) max: 2.52 in the early phase, 3.61
in the delayed phase) (Fig. 3). No other metastasis was de-
tected. Recurrence of endometrial cancer was suspected
and partial resection of the liver was planned for the soli-
tary metastasis.
The resected liver sample included a white nodule of
17 mm in diameter with a regular border macroscop-
ically (Fig. 4). Microscopic examination showed clear
eosinophil infiltration and granuloma with an
Fig. 1 Axial slice on enhanced CT in the equilibrium phase. A low
density area was detected in segment 4 of the liver (arrow)
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Table 1 Data from blood test of case 1. Eosinophilia was not shown and no tumor marker was elevated
TB 0.8 mg/dl (0.4–1.2) WBC 6000 /μl (3600–8900) AFP 1 ng/ml (<20)
AST 17 U/L (5–37) Neutro 55.2 % (37–72) PIVKA-II 12 mAU/ml (<40)
ALT 15 U/L (6–43) Lymph 37.6 % (25–48) CA19-9 <1 U/ml (<35)
ALP 245 U/L (110–348) Mono 3.7 % (2–12) CA125 16 U/ml (<37)
γGTP 13 U/L (0–75) Eosino 3.7 % (1–9)
BUN 11.6 mg/dl (9–21) Baso 2.2 % (0–2)
Cr 0.62 mg/dl (0.5–0.8) Hb 13.9 g/dl (11.2–15.2)
HCT 42 % (35.6–45.4)
Plt 2.43 106/μl (1.53 - 3.46)
TB total bilirubin, AST aspartate aminotransferase, ALT alanine aminotransferase, ALP alkaline phosphatase, gGTP γ glutamyl transpeptidase, BUN blood urea
nitrogen, Cr creatinine, WBC white blood cell, Neutro neutrophil, Lymph lymphocyte, Mono monocyte, Eosino eosinophil, Baso basophil, Hb hemogrobin, HCT
haematocrit, Plt platelet, AFP alpha‐fetoprotein, PIVKA-II protein induced by vitamin K absence or antagonist-II
Fig. 2 Axial slices of liver acquisition with volume acceleration flex on dynamic MRI in pre-contrast phase (a), arterial phase (b) and the hepatobiliary
phase (c). Coronal slice on enhanced MRI in the hepatobiliary phase (d). The lesion (arrows) gave a low intensity signal in all phases and a high intensity
signal in DWI (e)
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exogenous material in the center. There were no find-
ings consistent with malignancy. The exogenous ma-
terial had a lumen structure which was suspected to
be due to larva migrans. The slide was sent to the
National Institute of Infectious Diseases (NIID) to
identify the larvae. A detailed microscopic examin-
ation revealed that the larvae had Y-shape lateral cords
and renette cells, which are specific to Anisakis
(Fig. 5).
A PCR method using a specific primer pair was
performed for identification of the Anisakis species.
The methods of DNA amplification and sequencing
are described under a separate heading. This search
revealed that the larvae were Anisakis simplex sensu
stricto (Fig. 6).
These findings showed that the liver lesion was not
due to recurrence of endometrial cancer. The patient
has had no recurrence for 4 years.
Case 2
The patient was a 33-year-old woman who had been diag-
nosed with low-grade endometrial stromal sarcoma (LG-
ESS). She underwent extended total hysterectomy and
bilateral salpingo-oophorectomy. Pathological examin-
ation revealed clinical stage IB (FIGO 2008). High-dose
medroxyprogesterone acetate (400 mg/day) was adminis-
tered as adjuvant therapy.
Follow-up CT 8 months after surgery indicated swelling
of mediastinal lymph nodes. Biopsy of these nodes per-
formed by a respiratory surgeon revealed peripheral T-cell
lymphoma (PTCL), rather than recurrence of LG-ESS. She
was referred to the department of hematology. PET-CT
performed for pretreatment staging showed abnormal FDG
uptake in a nodule of 10 mm in diameter in the peritoneum
just below the lower median abdominal wall, in addition to
uptakes in mediastinal lymph nodes. The nodule was lo-
cated clearly extragastrointestinally. The patient was treated
with 3 cycles of a cyclophosphamide-adriamycin-vincristin-
prednisolone (CHOP) regimen. Post-treatment PET-CT
showed that the nodule in the peritoneum increased in size
to 16 mm with abnormal FDG uptake (SUVmax: 4.02 in
the early phase, 4.21 in the delayed phase) (Fig. 7), despite a
marked effect of the therapy on other lesions. Data from
blood tests before chemotherapy are shown in Table 2.
The PET-CT findings for the nodule were not compatible
with PTCL; therefore, exploratory laparotomy was per-
formed to examine possible dissemination of LG-ESS. The
nodule was on the omentum and partial omentectomy was
performed (Fig. 8). No other macroscopic lesion in the ab-
domen was found. Pathological examination revealed that
the nodule had an abscess with clear eosinophil infiltration.
An exogenous material that appeared to be a larva was
found in the center of the abscess. The larva body had col-
lapsed, but the specific Y-shape lateral cord was
recognizable (Fig. 9). Based on the experience of the first
case, we sent the slide to the NIID. The PCR method re-
vealed that the worm was Anisakis pegreffi (Fig. 6), which is
Fig. 3 Axial slice on PET-CT showing the liver lesion in the early (a) and delayed phase (b). FDG uptake was undetectable among physiological
uptake of the liver in the early phase; however, uptake elevated (SUVmax: 2.52 to 3.61) and was detectable in the delayed phase
Fig. 4 Macroscopic findings in the resected liver, showing a white
node with a regular border of about 2 cm in diameter
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rare as an infectious pathogen in human. These findings
showed that the patient did not have recurrent LG-ESS.
The patient has had no recurrence of LG-ESS for 2 years
and that of PTCL for a year.
Imaging parameters of CT, MRI, and PET-CT
CT: The device is an Acquilion ONE (Toshiba Medical
Systems, Otawara, Japan) by using a tube voltage of 120
kVp and tube current varied between 96 mA and
160 mA. Slice thickness is 5 mm for abdominal scan-
ning as a post-operative follow up in a cancer patient.
MRI: The device is a Discovery MR750 3.0 T (GEHealth-
care, Waukesha, Wisconsin, USA) using 32-channel torso
coil as a receiver. Liver acquisition with volume acceleration
flex (LAVA-Flex) is practiced with EOB dynamic MRI in
our institute. The acquisition sequence is LAVA Flex with
parameters as follows: Time of repectition (TR)/time of
echo (TE) = 3.9/1.7 msec, flip angle = 12 o, slice thickness/
gap = 3.6/1.8 mm, matrices = 256 × 256, acquisition time =
19 s. Gd-EOB-DTPA: Primovist® (Bayer Healthcare AG,
Berlin, Germany)-enhanced images in the hepatobiliary
phase are taken at 15 min after contrast injection.
PET-CT: Biograph mCT (Siemens Medical Solutions,
Knoxville, TN, USA). In our institute, patients routinely
receive DPS for differentiation. Patients were adminis-
tered 3.7 MBq/kg of FDG and received routine PET-CT
DPS at 1 and 2 h after administration. Data were ana-
lyzed on an AZE workstation (AZE Ltd, Tokyo, Japan).
Molecular investigation
Identification of anisakid nematodes (DNA amplification
and sequencing)
The worm body was scratched from the deparaffinized
slide under stereoscopic microscopy and placed in a
Fig. 5 a Sagittal slice of the larva, showing a wave-shaped (cross-striated) border (white line). b Axial slice of the larva, showing a Y-shaped lateral
cord (arrows 1) and a renette cell (arrow 2). These findings are characteristics of Anisakis
Fig. 6 Primers used for genetic identification of Anisakis and sequences obtained
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plastic tube. DNA was extracted using proteinase K
(Qiagen) and SDS (Sigma-Aldrich) [10]. The entire in-
ternal transcribed spacer (ITS) region (ITS1, 5.8S rDNA
and ITS2) was amplified by PCR using the primers NC5
and NC2 in the first round. Then nested PCR was per-
formed in the second round to amplify a specific region
in the ITS1 using the following primers that were origin-
ally constructed: AniT1F1: 5′-GTTGAACAACGGTGA
CCAATTTGGC-3′, and AniT1R1: 5′-. PCR was con-
ducted by the method indicated in reference [10]. An
amplification product of 208 bp was obtained. Se-
quence similarities were determined by a BLAST
search of the DNA Data Bank of Japan (DDBJ) (http://
www.ddbj.nig.ac.jp/index-e.html). Sequence alignment and
comparison was facilitated by the GENETYX-WIN pro-
gram (ver. 7.0, Software Development Co, Tokyo, Japan).
Investigation for the mechanism of FDG uptake
(immunochemical staining using anti-bodies to GLUT-1 and
HK-2)
Once FDG is uptaken to cells through the GLUT-1 and
phosphorylated by HK-2, FDG is unable to pass out of
cells unless dephosphorylated by glucose-6-phosphatase
(G6P). Because malignant cells have a high ratio of HK-
2/G6P, they present an elevation of FDG uptake in de-
layed phase in dual-phase scanning (DPS) of PET-CT.
Since both cases indicated the elevation, recurrence was
a stronger consideration among other differential
diagnoses.
Cases of parasitosis suspected as malignancy in PET
have been previously reported but are very rare [11–13].
There are no reports investigating the mechanisms of
FDG uptake in parasitosis granuloma. We researched
them to develop ways to differentiate them by investigat-
ing overexpression of GLUT-1 and HK-2.
GLUT-1 expression was evaluated immunohistochemi-
cally using rabbit polyclonal anti-Glucose Transporter
GLUT1 antibody (ab652, Abcam, Cambridge, UK) at a
dilution of 1:500. HK-2 expression was evaluated with
rabbit polyclonal anti-Hexokinase Type II (AB3279,
Chemicon International, Temecula, USA) diluted at
1:500. Immunohistochemical staining was performed
using the Leica Bond-Max automatic immunostainer
and the Bond Polymer Refine Detection kit (Leica).
In both cases, only macrophages were positive for both
antibodies; GLUT-1 and HK-2. The eosinophils, which
Fig. 7 Axial slice on PET-CT after CHOP therapy in the early (a) and delayed phase (b). The lesion had increased in size compared with pre-treatment
and showed FDG uptake (SUVmax: 4.02 to 4.21)
Table 2 Data from blood test of case 2. Eosinophilia was not shown and sIL2R was elevated due to lymphoma
TB 0.5 mg/dl (0.4–1.2) WBC 5400 /μl (3600–8900) sIL2R 381 U/ml (<20)
AST 13 U/L (5–37) Neutro 53.3 % (37–72) CA125 11 U/ml (<37)
ALT 7 U/L (6–43) Lymph 34.9 % (25–48)
ALP 237 U/L (110–348) Mono 5.8 % (2–12)
LDH 184 U/L (0–75) Eosino 5.4 % (1–9)
BUN 10.4 mg/dl (9–21) Baso 0.6 % (0–2)
Cr 0.6 mg/dl (0.5–0.8) Hb 13 g/dl (11.2–15.2)
HCT 39.1 % (35.6–45.4)
Plt 2.5 106/μl (1.53–3.46)
TB total bilirubin, AST aspartate aminotransferase, ALT alanine aminotransferase, ALP, alkaline phosphatase, LDH lactate dehydrogenase, BUN blood urea nitrogen,
Cr creatinine, WBC white blood cell, Neutro neutrophil, Lymph lymphocyte, Mono monocyte, Eosino eosinophil, Baso basophil, Hb hemogrobin, HCT haematocrit, Plt
platelet, sIL-2R soluble interleukin-2 receptor
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were infiltrated around worm bodies, were negative for
them (Figs. 10, 11). These results suggest that eosinophil
infiltration may not boost FDG uptake or have any spe-
cific roles. Instead, the reason for FDG uptake to parasit-
osis granuloma may be the macrophages, which is
commonly seen in granulomas.
Discussion
Extragastrointestinal anisakiasis accounts for 0.45 %
of cases of anisakiasis in Japan [14]. The condition is
caused by an Anisakis worm penetrating the bowel
wall and forming an intra-abdominal colony. Cases in
the omentum have been described in Japan and Italy
[7, 15]. Occurrence as a solitary liver lesion is par-
ticularly rare, with the only examples found in eight
cases reported in Japan [16, 17]. Most cases of
extragastrointestinal anisakiasis are asymptomatic and
detected incidentally.
In the present two cases, malignant metastatic tumor
was indicated as first choice of differential diagnosis by
two imaging modalities. Dynamic MRI using contrast
agent is often performed as the detailed examination for
hepatic tumor, as in case 1. Low signal in hepatobilliary
phase without early enhancement is compatible with
metastatic tumor. However, because Gd-EOB-DTPA
contrasting is dependent on expression of OATP1B1/3
[18], and parasitic granuloma does not necessarily show
expression of OATP1B1/3, Gd-EOB-DTPA may not be
useful for differentiating between metastatic tumor and
parasitic granuloma. Using Gd-EOB-DTPA contrast ben-
efits in clarifying the tumor location. The diagnostic effi-
cacy of PET-CT for extragastrointestinal anisakiasis has
not been examined because of the rarity of the disease.
Our cases indicated that lesions of extragastrointestinal
anisakiasis present with abnormal FDG uptake and were
difficult to distinguish from a malignant tumor. Anisakis
cannot live in the human body and die immediately, and
thus FDG uptake was not directly associated with the
worm body, but with inflammatory cells around the
body. Dual-phase scanning is a well-known method for
distinguishing between inflammation and malignancy
[19–22], based on the observation that malignant lesions
have elevated FDG uptake in the delayed phase com-
pared with the early phase. However, the lesions in both
of our cases showed elevation in delayed phases, espe-
cially in case 1. Without previous CT or MRI, the tumor
might not have been detected using only the early phase
scan. There has been a report of an anisakiasis case
without FDG uptake [16] and the uptake decreased with
time in our second case, suggesting that FDG uptake in
anisakiasis lesions may decrease with time. This may
help to distinguish it from malignancy, but it remains
difficult to observe without therapy for cases in which
malignancy is suspected.
Anisakiasis occurs due to eating of infected raw fish, such
as mackerel, and horse mackerel. Consumption of raw fish
is common in Asia, including Japan, and Northern Europe
[23], and there is a recent trend to expansion of this behav-
ior in the United States [24]. Food and drug administration
in the United States and European Food Safety Authority
in Europe recommend the frozen stock required for raw
fish to prevent parasitosis. Increased use of imaging modal-
ities such as MRI and PET-CT is likely to lead to more inci-
dental findings of asymptomatic lesions [25], and this may
lead to an increase in cases similar to those in this report.
This is a concern because differential diagnosis from a ma-
lignant tumor is difficult for these lesions. The difficulty
was provided by time lag. There is a time lag between infec-
tion and detection of a lesion, since generating a granuloma
or an abscess in anisakiasis takes 2 months to 2 years [26].
Fig. 8 Intra-abdominal findings in exploratory laparotomy. The
lesion was located on the omentum with adhesion to the
parietal peritoneum
Fig. 9 The nodule had an abscess with clear eosinophil infiltration.
The larva body had collapsed, but the specific Y-shaped lateral cord
was recognizable (arrow)
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The prior imaging to the detection of the tumor was
10 months in case 1, and 2 months in case 2. It is suspected
that the patients were infected and granuloma formation
occurred during this interval. The hematological or sero-
logical acute reaction of infection and the patient’s memory
of symptoms or food consumption can be lost due to this
time lag. In this situation, a test for eosinophilia, a specific
antibody test and history taking, which are important in
diagnosis of parasitosis, are less useful. In fact, eosinophilia
was not seen in either of our cases and a specific antibody
for Anisakis was negative in the first case. And we retook
the patients’ history retrospectively after surgery, neither of
the patients remembered a characteristic dietary history.
The difficulty of diagnosing is not only because of the
vagueness of memory, but is also related to the existence of
asymptomatic cases. Our two cases were also asymptomatic
cases and there were no imaging findings on contrast CT.
Generally, Anisakis larvae bite the intestinal wall, which
causes acute severe abdominal pain. The pain is caused
mainly by allergic reaction, rather than mechanical stimu-
lus. Even in extragastrointestinal anisakiasis, which larvae
penetrate the wall of the gastrointestinal tract, many cases
are detected incidentally. There seems to be many asymp-
tomatic cases.
The risk of recurrence of a primary malignancy should
also be considered. In our first case, the risk of recur-
rence of endometrial cancer was intermediate, at about
10 % at 20 months after initial therapy [27]. In the
Fig. 10 In case 1, macrophages around abscess (a HE, arrows) were positive for GLUT-1 on the cell membrane (b, c, arrows) and HK-2 in the cytoplasm
(d, e, arrows). Extensive eosinophil infiltrate (f HE, throughout the whole figure) were negative for GLUT-1 (g) and HK-2 (h)
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second case, the patient had stage I LG-ESS. The recur-
rence risk for this cancer is over 30 %, even in stage I, al-
though the period of progression-free LG-ESS is
generally longer than 8 months [28]. Therefore, both
cases had a relatively low risk of recurrence, but this in-
formation was difficult to include in the diagnosis with
certainty. In addition to the complexity of FDG uptake
in PET-CT, the lesion location may also increase the dif-
ficulty of diagnosis. If a lesion is detected in the intes-
tinal wall or intramesentery, in which anisakiasis is
relatively common, recurrence of gynecological cancer is
less likely. However, a lesion in the peritoneum or liver
is less likely to be due to extragastrointestinal anisakiasis,
and this is also a common site of tumor recurrence.
Cases of extragastrointestinal anisakiasis in the uterus
[29, 30] and ovary [31] have also been reported, indicat-
ing that differential diagnosis of such lesions is also
required.
Generally, inflammatory lesions such as pneumonia
and abscess, which need to be differentiated with malig-
nancy, include macrophages and neutrophils. These cells
increase the glucose uptake, but the changes seen in the
delayed phase in DPS differs with cancer cells because of
the difference of HK-2/G6P ratio. The two cases we re-
port had eosinophilic granuloma. We speculated that the
elevation of SUV in the delayed phase may be caused by
eosinophils, and investigated their feature by immuno-
chemical straining using anti-GLUT-1 and anti-HK-2
Fig. 11 In case 2, macrophages around abscess (a HE, arrows) were positive for GLUT-1 on the cell membrane (b, c, arrows) and HK-2 in the cytoplasm
(d, e, arrows). Extensive eosinophil infiltrate (f HE, throughout the whole figure) were negative for GLUT-1 (g) and HK-2 (h)
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antibodies. However, against our expectation, eosinophils
showed negative expression of GLUT-1 and HK-2, and
only macrophages were strained. Although we have not
investigated the expression of G6P, the expression HK-2
in macrophages may cause the elevation of uptake in in-
flammatory lesion in is the delayed phase. Thus, DPS is
not necessarily superior to other modalities in distin-
guishing malignancy and inflammation. New imaging
modalities such as PET-CT allow an “abnormality” to be
detected incidentally. It is important to determine
whether a lesion found on PET-CT is truly abnormal,
and this limitation of new technologies should be
recognized.
In our cases, a genetic test was used to define the patho-
gen. The Anisakis worm collapses in the human body and
this may cause difficulty with diagnosis, as in our second
case. The PCR methods described here are useful in these
cases. In addition, improved definition of species among
Anisakis larvae might bring new insights. No studies have
been reported about the frequency of species in extragas-
trointestinal anisakiasis. However, Umehara A. et al. re-
ported that 99 % of all human anisakiasis are due to
Anisakis simplex sensu stricto [32]. Anisakis pegreffi is
relatively common among fish that are landed [33]. This
discrepancy is explained by the difference of the larvae’s
ability to penetrate to the fish muscle, thus causing
ingested by human [34–36]. In both cases included in the
present study, it is thought that the larvae penetrated the
gastrointestinal wall. Thus, the case of extragastrointest-
inal anisakiasis of Anisakis pegreffi is very rare and inter-
esting. Accumulation of cases are required to clarify the
epidemiology of extragastrointestinal anisakiasis and iden-
tify routes of infection.
Conclusion
We experienced two cases of anisakiasis that were initially
suspected to be recurrence of gynecological cancer on
PET-CT. These cases suggest that anisakiasis should be a
differential diagnosis for a lesion presenting with FDG up-
take on PET-CT. Our results also indicate that it is difficult
to distinguish anisakiasis from a recurrent tumor using
PET-CT and there is no specific mechanism of FDG uptake
in parasitosis granuloma. These findings are important be-
cause current dietary habits and use of imaging modalities
suggest that similar cases will increase worldwide.
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